Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs Progressive Corp (PGR) Price & Performance

GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.

The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.

Progressive Corporation (PGR) trades at $222.88, up 1.18% with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with $87.6B revenue (2025), 12.85% net margin, and attractive valuation at 11.18 P/E. Recent earnings show mixed quarterly performance with two beats and two misses, while cash flow remains stable with $17.55B operating cash flow.

Outlook remains positive with analyst consensus at $222.23 target and 38% buy ratings, though competition in personal auto insurance presents headwinds. The stock's current proximity to resistance at $222 suggests potential consolidation, while strong ROE of 34.94% supports long-term growth potential despite elevated RSI levels indicating overbought conditions.